Prophylactic anticoagulation refers to the preventive use of anticoagulant medications to reduce the risk of blood clots, specifically in patients who are at a higher risk of developing [venous thromboembolism (VTE)](). This approach is particularly relevant in cancer patients, who have a significantly increased risk of thrombotic events due to the [hypercoagulable state]() induced by cancer and its treatments.
